Showing results (11-20 of 311) with videos related to
Sort By:
Pageof 32
Best Practice & Research. Clinical Endocrinology & Metabolism|March 28, 2026
Resistant prolactinomasSusan L SamsonNeuroendocrinology|March 21, 2015
Pasireotide in Acromegaly: An Overview of Current Mechanistic and Clinical DataSusan L SamsonCurrent Opinion in Endocrinology, Diabetes, and Obesity|February 14, 2013
GLP-1R agonist therapy for diabetes: benefits and potential risksSusan L Samson, Alan GarberJournal of Diabetes and Its Complications|January 29, 2013
Potential of incretin-based therapies for non-alcoholic fatty liver diseaseSusan L Samson, Mandeep BajajMetabolic Syndrome and Related Disorders|May 21, 2014
Cardiovascular effects of incretin therapy in diabetes careJongoh Kim, Susan L SamsonTrends in Endocrinology and Metabolism: TEM|March 1, 2006
Gene therapy for diabetes: reinventing the isletSusan L Samson, Lawrence ChanEndocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 28, 2014
AACE/ACE Disease State Clinical Review: Dopamine Agonists for Hyperprolactinemia and the Risk of Cardiac Valve DiseaseSusan L Samson, Shereen EzzatInternational Journal of Molecular Sciences|April 20, 2017
Suppression of GHS-R in AgRP Neurons Mitigates Diet-Induced Obesity by Activating ThermogenesisChia-Shan Wu, Odelia Y N Bongmba, Jing Yue, et al.BMC Physiology|October 24, 2017
Adiponectin is required for maintaining normal body temperature in a cold environmentQiong Wei, Jong Han Lee, Hongying Wang, et al.Current Diabetes Reports|October 22, 2016
A Plethora of GLP-1 Agonists: Decisions About What to Use and WhenSusan L Samson, Alan J GarberPageof 32